Allianz Asset Management Gmb H Denali Therapeutics Inc. Transaction History

Allianz Asset Management Gmb H

$69.7 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$16.2 - $23.18 $11,340 - $16,226	700 Added 4.76%	15,400 $330,000
Q2 2023 Aug 11, 2023	BUY	$23.37 - $32.96 $79,458 - $112,064	3,400 Added 30.09%	14,700 $433,000
Q3 2022 Nov 08, 2022	SELL	$25.97 - $38.53 $91,414 - $135,625	-3,520 Reduced 23.75%	11,300 $347,000
Q2 2022 Aug 12, 2022	SELL	$20.88 - $35.19 $62,640 - $105,570	-3,000 Reduced 16.84%	14,820 $436,000
Q1 2022 May 13, 2022	SELL	$29.0 - $47.27 $531,425 - $866,222	-18,325 Reduced 50.7%	17,820 $573,000
Q4 2021 Feb 11, 2022	BUY	$42.59 - $55.02 $741,491 - $957,898	17,410 Added 92.93%	36,145 $1.62 Million
Q3 2021 Nov 10, 2021	SELL	$48.48 - $78.23 $228,825 - $369,245	-4,720 Reduced 20.12%	18,735 $945,000
Q1 2021 May 13, 2021	SELL	$53.8 - $81.53 $473,709 - $717,871	-8,805 Reduced 27.29%	23,455 $1.34 Million
Q4 2020 Feb 16, 2021	BUY	$36.89 - $93.56 $1.19 Million - $3.02 Million	32,260 New	32,260 $2.7 Million
Q1 2020 May 14, 2020	SELL	$14.2 - $27.98 $470,786 - $927,648	-33,154 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$14.4 - $19.99 $404,092 - $560,959	-28,062 Reduced 45.84%	33,154 $577,000
Q3 2019 Nov 13, 2019	SELL	$15.32 - $21.92 $689 - $986	-45 Reduced 0.07%	61,216 $952,000
Q2 2019 Aug 08, 2019	SELL	$18.5 - $28.14 $713,378 - $1.09 Million	-38,561 Reduced 38.63%	61,261 $1.27 Million
Q1 2019 May 13, 2019	BUY	$17.99 - $24.65 $155,037 - $212,433	8,618 Added 9.45%	99,822 $2.32 Million
Q4 2018 Feb 14, 2019	SELL	$13.88 - $21.75 $1.83 Million - $2.87 Million	-132,076 Reduced 59.15%	91,204 $1.86 Million
Q3 2018 Nov 13, 2018	SELL	$12.46 - $21.74 $168,334 - $293,707	-13,510 Reduced 5.71%	223,280 $4.85 Million
Q2 2018 Aug 13, 2018	BUY	$15.25 - $21.02 $7,625 - $10,510	500 Added 0.21%	236,790 $3.61 Million
Q1 2018 May 14, 2018	BUY	$15.36 - $24.8 $564,403 - $911,276	36,745 Added 18.41%	236,290 $4.65 Million
Q4 2017 Feb 13, 2018	BUY	$15.04 - $21.45 $3 Million - $4.28 Million	199,545	199,545 $3.12 Million

Others Institutions Holding DNLI

# of Institutions

226

Shares Held

119M

Call Options Held

60.6K

Put Options Held

48.4K

Black Rock Inc. New York, NY

13.2M
Shares

$307 Million
0.01% of portfolio
Baillie Gifford & CO

12.3M
Shares

$287 Million
0.2% of portfolio
Vanguard Group Inc Valley Forge, PA

11.2M
Shares

$260 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

10.7M
Shares

$250 Million
0.06% of portfolio
Capital Research Global Investors Los Angeles, CA

7.91M
Shares

$184 Million
0.05% of portfolio

View Full List

About Denali Therapeutics Inc.

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $3.13B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

More about DNLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.

Account